Slovenia JAZMP · August 11, 2026

Litfulo (ritlecitinib): Direct Healthcare Professional Communication on cardiovascular risk mitigation

Original title: Litfulo▼ (ritlecitinib): obvestilo za zdravstvene delavce

Direct healthcare professional communication issued with updated recommendations to reduce risk of serious cardiovascular adverse events.

Low obligation Product class Pharmaceuticals Slovenia Pharmacovigilance

Zdravstvene delavce obveščamo, da je na spletni strani JAZMP objavljeno neposredno obvestilo (angl. DHPC – Direct Healthcare Professional Communication) o posodobljenih priporočilih za zmanjšanje tveganj za pomembne srčno-žilne neželene dogodke, […]

Read the official source ↗

Published by Slovenia JAZMP. HealthSignal links to the original document; the summary above is extracted from the source text.